molab.ai provides a step change in drug discovery through impact-oriented applications of its cutting-edge technology.
End-to-end discovery platform
Platform integrating in-silico design and evaluation with wet lab validation. Iterative combinations of ultra-large virtual libraries screens with both AI/ML and physic-based methods, generative molecular design as well as wet lab validation accelerate projects substantially.
ADMET prediction engine
Proven ADMET predictions and a reliable confidence indicator accelerating hit-to-lead and lead optimization projects by 25% – 40% through actionable recommendations and very robust performance in novel chemical space.
Compound optimization suite
GenAI-powered and curated suggestions for novel, alternative molecular structures optimized for potency, selectivity and desirable ADMET properties.
ABOUT
We are a purpose-driven AI company that combines scientific excellence, impact orientation and entrepreneurial drive. We leverage our unique technology and hands-on approach to help our clients unlock substantial value, fast.
Our Vision
Precision molecules for the benefit of patients, people and the planet.
Our Misson
Market-leading AI technology to create better molecules faster.